Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joris Wilms currently holds 30,600 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joris Wilms has been a net seller of YMAB stock. They have purchased $0 and sold $73.5K worth of shares.
Joris Wilms's most recent insider trade was on Sep 16, 2025, when they sold 39,301 shares at $0.00 per share.
Joris Wilms serves as Executive at Y-mAbs Therapeutics, Inc. (YMAB). They have executed 6 insider transactions totaling $73.5K over their tenure at the company.
Joris Wilms holds the position of Executive at Y-mAbs Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Joris Wilms has shown a selling trading pattern, with $0 in total purchases and $73.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joris Wilms was on Sep 16, 2025, when they sold $110.1K worth of YMAB shares. This transaction involved 12,799 shares at $8.60 per share.
Joris Wilms currently owns 30,600 shares of Y-mAbs Therapeutics, Inc. (YMAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joris Wilms's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joris Wilms has 6 Form 4 filings on record as an insider at Y-mAbs Therapeutics, Inc..
Set alerts for Joris Wilms and 40,000+ other insiders.